{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:20Z","timestamp":1787261000981,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005971","name":"Deutsche Herzstiftung","doi-asserted-by":"publisher","award":["S\/06\/23"],"award-info":[{"award-number":["S\/06\/23"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahj.2026.107519","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:32:54Z","timestamp":1782052374000},"page":"107519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic impact of combined inflammatory markers in patients undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"301","author":[{"given":"Francesca Maria","family":"Di Muro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107519_bib0001","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamacardio.2018.2258","article-title":"Efficacy and safety of further lowering of low-density lipoprotein cholesterol in patients starting with very low levels: a meta-analysis","volume":"3","author":"Sabatine","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0002","unstructured":"Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005. https:\/\/doi.org\/10.1016\/S0140-6736(05)."},{"key":"10.1016\/j.ahj.2026.107519_bib0003","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107519_bib0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.ahj.2026.107519_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120411","article-title":"Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and intensity of lipid-lowering therapy in patients with established cardiovascular disease","author":"Schuitema","year":"2025","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2026.107519_bib0006","article-title":"Prognostic impact of residual inflammatory and triglyceride risk in statin-treated patients with well-controlled LDL cholesterol and atherosclerotic cardiovascular disease","author":"Di Muro","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0007","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.jacc.2019.01.077","article-title":"Residual inflammatory risk in patients with low LDL cholesterol levels undergoing percutaneous coronary intervention","volume":"73","author":"Guedeney","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention","author":"Bay","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107519_bib0009","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107519_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-39691-1","article-title":"Residual inflammatory risk and clinical outcomes after contemporary percutaneous coronary intervention: a systematic review and meta-analysis","volume":"16","author":"Romeo","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.ahj.2026.107519_bib0011","unstructured":"PM Ridker. A test in context high-sensitivity C-reactive protein. 2016. 10.1016\/j.jacc.2015.11.037."},{"key":"10.1016\/j.ahj.2026.107519_bib0012","article-title":"Association of neutrophil-to-lymphocyte ratio with clinical outcomes after percutaneous coronary intervention","author":"Oliva","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0013","series-title":"Guideline on haemoglobin cutoffs to define anaemia in individuals and populations","year":"2024"},{"key":"10.1016\/j.ahj.2026.107519_bib0014","doi-asserted-by":"crossref","unstructured":"Editorial Board. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105 (2024): S117-S31. https:\/\/doi.org\/10.1016\/s0085-2538(24)00110-8.","DOI":"10.1016\/S0085-2538(24)00110-8"},{"key":"10.1016\/j.ahj.2026.107519_bib0015","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107519_bib0016","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107519_bib0017","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107519_bib0018","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association\/American stroke association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2026.107519_bib0019","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2026.107519_bib0020","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0021","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/eurheartj\/ehaa160","article-title":"Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107519_bib0022","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Anti-inflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107519_bib0023","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107519_bib0024","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107519_bib0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2026.107519_bib0026","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molimm.2022.04.003","article-title":"IL-6 regulates induction of C-reactive protein gene expression by activating STAT3 isoforms","volume":"146","author":"Ngwa","year":"2022","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ahj.2026.107519_bib0027","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMra2206346","article-title":"Humoral innate immunity and acute-phase proteins","volume":"388","author":"Mantovani","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107519_bib0028","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/bj2740133","article-title":"Reoxygenation-dependent decrease in mitochondrial NADH:CoQ reductase (Complex I) activity in the hypoxic\/reoxygenated rat heart","volume":"274","author":"Hardy","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.ahj.2026.107519_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2013.04.023","article-title":"Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction","volume":"62","author":"Yan","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.116.304072","article-title":"Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction","volume":"116","author":"Hofmann","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2026.107519_bib0031","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.imbio.2012.05.029","article-title":"Neutrophil - CD4+CD25+ T regulatory cell interactions: a possible new mechanism of infectious tolerance","volume":"218","author":"Lewkowicz","year":"2013","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.ahj.2026.107519_bib0032","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1046\/j.1523-1755.1998.00947.x","article-title":"Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension","volume":"53","author":"Vaziri","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.ahj.2026.107519_bib0033","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/CIRCINTERVENTIONS.109.889915","article-title":"Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysise","volume":"2","author":"Ishii","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2026.107519_bib0034","article-title":"Neutrophil-mediated effects on hemostasis and thrombosis: unraveling their complex interaction in thrombotic events","author":"Hassani","year":"2025","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ahj.2026.107519_bib0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2023.05.031","article-title":"Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: analyses from ENGAGE AF- TIMI 48 trial","volume":"386","author":"Fagundes","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2024-325396","article-title":"Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary intervention","author":"Di Muro","year":"2025","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2026.107519_bib0037","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjcard.2019.06.001","article-title":"Impact of chronic kidney disease and anemia on outcomes after percutaneous coronary revascularization","volume":"124","author":"Cilia","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0038","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejim.2022.05.004","article-title":"Low serum albumin: a neglected predictor in patients with cardiovascular disease","volume":"102","author":"Manolis","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ahj.2026.107519_bib0039","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/jce.16537","article-title":"Impact of anemia on clinical outcomes in atrial fibrillation patients on oral anticoagulants: a prognostic meta-analysis","volume":"36","author":"Amin","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ahj.2026.107519_bib0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600181X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287032600181X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:23:32Z","timestamp":1787257412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287032600181X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S000287032600181X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107519","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of combined inflammatory markers in patients undergoing percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107519"}}